Dr. Seung T Lee
Claim this profileUniversity of Maryland
Area of expertise
Lymphoma
Seung T Lee has run 5 trials for Lymphoma. Some of their research focus areas include:
Non-Hodgkin's Lymphoma
Seung T Lee has run 4 trials for Non-Hodgkin's Lymphoma. Some of their research focus areas include:
Affiliated Hospitals
University Of Maryland
Greenebaum Comprehensive Cancer Center
Clinical Trials Seung T Lee is currently running
Tazemetostat + Lenalidomide + Rituximab
for Follicular Lymphoma
The participants of this study would have relapsed/refractory follicular lymphoma. Follicular lymphoma is a type of blood cancer. It is referred to as 'relapsed' when the disease has come back after a period of improvement after that follows a treatment regimen and 'refractory' when treatment no longer works. Stage 1 of this trial will study the safety and the level that adverse effects of each of the study drug combinations can be tolerated (known as tolerability). It is also designed to establish a recommended study drug dosage for stage 2 and 3. Stage 1 of the study is completed. Stages 2 and 3 will evaluate and compare how long participants live without their disease getting worse when receiving the study drug in combination with other drug treatment versus the placebo (dummy drug) in combination with other drug treatment.
Recruiting
1 award
Phase 3
4 criteria
IKS03
for B-Cell Lymphoma
This first-in-human study will evaluate the recommended dose for further clinical development, safety, tolerability, antineoplastic activity, immunogenicity, pharmacokinetics and pharmacodynamics of IKS03, a CD19 targeting antibody-drug conjugate, in patients with advanced B cell non-Hodgkin lymphoma (NHL).
Recruiting
1 award
Phase 1
More about Seung T Lee
Clinical Trial Related
6 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Seung T Lee has experience with
- Rituximab
- Lenalidomide
- Brentuximab Vedotin
- LOXO-305
- Lacutamab
- Placebo
Breakdown of trials Seung T Lee has run
Lymphoma
Non-Hodgkin's Lymphoma
Peripheral T-Cell Lymphoma
B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Seung T Lee specialize in?
Seung T Lee focuses on Lymphoma and Non-Hodgkin's Lymphoma. In particular, much of their work with Lymphoma has involved CD19 positive patients, or patients who are undergoing treatment.
Is Seung T Lee currently recruiting for clinical trials?
Yes, Seung T Lee is currently recruiting for 2 clinical trials in Baltimore Maryland. If you're interested in participating, you should apply.
Are there any treatments that Seung T Lee has studied deeply?
Yes, Seung T Lee has studied treatments such as Rituximab, Lenalidomide, Brentuximab Vedotin.
What is the best way to schedule an appointment with Seung T Lee?
Apply for one of the trials that Seung T Lee is conducting.
What is the office address of Seung T Lee?
The office of Seung T Lee is located at: University of Maryland, Baltimore, Maryland 21201 United States. This is the address for their practice at the University of Maryland.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.